General Info

Founded in 1990, CMC ICOS Biologics aims at discovering, developing and marketing therapeutic products. CMC ICOS Biologics works toward developing treatments for medical conditions, such as benign prostatic hyperplasia, hypertension, pulmonary arterial hypertension, cancer and inflammatory diseases. The company has a joint venture with Eli Lilly and Company and markets its product Cialis for the treatment of erectile dysfunction. The company also manufactures Tadalafil for treating the enlargement of the prostate and IC485 chronic obstructive pulmonary disease. The company has expertise in cell line and process development and specializes in delivering protein-based materials and recombinant protein products for preclinical and clinical trials. CMC ICOS Biologics is headquartered in Bothell, Wash.